Letrozole: indications, side effects and advice for breast cancer patients

Letrozole belongs to a class of drugs called non-steroidal aromatase inhibitors. Its action consists of reducing the amount of estrogen produced to slow or stop the growth of some types of cancer cells that need estrogen to grow.

 

What is letrozole and what is it used for?

Letrozole belongs to a group of drugs called aromatase inhibitors, which is a hormonal treatment to fight hormone-dependent breast cancer that is stimulated by estrogen, which are female sex hormones. The mechanism of action of this drug reduces the amount of estrogen by blocking an enzyme involved in its production.

 

How letrozole is used in chemotherapy

  • Letrozole can be used as adjuvant treatment, that is, after chemotherapy, to reduce the risk of the cancer recurring.
  • In some cases, it can be combined with chemotherapy in patients with advanced or metastatic breast cancer.
  • Letrozole can be used after treatment with tamoxifen.
  • It can also be combined with other treatments, depending on the patient and the recommendation of the oncologist.

Duration and administration

  • Adjuvant treatment (after surgery): it is usually administered for 5 years to reduce the risk of cancer recurrence.
  • Extended adjuvant treatment: in some cases, after completing 5 years of treatment with tamoxifen, letrozole can be continued for another 3-5 years.
  • Advanced or metastatic breast cancer: letrozole treatment can be continued until disease progression is evident.

 

Side effects of letrozole

Side effects described:

  • Hot flushes: similar to the symptoms of menopause, this is a common effect of aromatase inhibitors
  • Joint and muscle pain: can cause significant discomfort, known as arthralgia.
  • Fatigue or tiredness: this is an effect that can affect quality of life during treatment.
  • Weight gain: some people may experience a slight increase in body weight.
  • Increased cholesterol levels: may contribute to the development of hypercholesterolemia.
  • Headache: can range from mild to severe and can be persistent during treatment.
  • Nausea: can be mild or severe, and in some cases can lead to vomiting.
  • Loss of bone density (osteoporosis): can make bones more fragile and increase the risk of fractures.

Less common side effects:

  • Liver problems: include alterations in liver function tests and, in rare cases, hepatitis.
  • Cardiovascular problems: letrozole can increase the risk of hypertension, cardiovascular disease and, in some people, can exacerbate pre-existing heart disease.
  • Thrombosis: although less common, there is a risk of blood clots forming.
  • Skin reactions: some people may experience rashes, itching or other skin reactions.

 

Precautions and contraindications for letrozole

Alcohol consumption: alcohol consumption can aggravate side effects

  • Hot flashes and sweating: letrozole can cause hot flashes and sweating as common side effects. In this sense, alcohol consumption can intensify these symptoms, making them more frequent and severe.
  • Nausea and vomiting: both letrozole and alcohol can cause nausea and vomiting. Combining them can increase the likelihood and intensity of these side effects.
  • Effectiveness of the medication: although there is no direct evidence that alcohol reduces the effectiveness of letrozole, alcohol consumption can interfere with the body’s ability to process the medication optimally.
  • Liver stress: letrozole and alcohol are metabolized by the liver. Consuming alcohol while taking letrozole can increase stress on the liver, which could lead to liver problems.

Situations in which letrozole should be avoided:

  • Premenopausal and non-menopausal patients: Letrozole is only indicated for women who have gone through the menopause and should not be used by women who still have menstrual cycles.

Allergies to components of the medication:

  • Allergic reactions: patients who have experienced allergies to letrozole or any of its components should avoid its use. Allergic reactions may include hives, difficulty breathing and anaphylaxis.

Severe liver problems:

  • Liver disease: patients with severe liver disease, especially cirrhosis, should avoid letrozole due to the risk of worsening liver function.

Osteoporosis and osteopenia:

  • Low bone density: since letrozole can decrease bone density, patients with osteoporosis or osteopenia should be carefully evaluated before starting treatment, and may need additional measures to protect bone health.

 

Interactions with other medications:

  • Tamoxifen and other anti-estrogens: the concomitant administration of letrozole with tamoxifen or other anti-estrogens should be avoided, as these substances can diminish the pharmacological action of letrozole.
  • Estrogens: the use of treatments containing estrogens can reduce the effectiveness of letrozole, so it is important to avoid combining these medications.
  • Tibolone: tibolone, a medication used to treat menopausal symptoms, can also interfere with the effectiveness of letrozole.
  • Medicines that affect the cytochrome P450 enzyme system: letrozole inhibits the CYP2A6 isoenzymes and, to a moderate degree, the CYP2C19 isoenzymes of cytochrome P450, and although these interactions are not common, it is important to bear in mind that other medicines that affect these enzymes can alter the effectiveness of letrozole.

 

Tips for coping with letrozole treatment

  • Hydration: it is essential to drink enough water (at least 2-2.5 liters a day) to maintain good hydration and help the kidneys eliminate toxins.
  • Small, frequent meals: eating small portions throughout the day instead of three large meals can help reduce nausea.
  • Soft, easy-to-digest foods: opting for foods such as rice, bananas, applesauce and toast can be easier on the stomach.
  • Lean proteins: consuming lean proteins such as chicken, fish, eggs and legumes is essential for tissue repair and maintaining muscle mass.
  • Fruit and vegetables: include a variety of fruit and vegetables in your daily diet, these foods are rich in vitamins, minerals and antioxidants that can strengthen the immune system.
  • Avoid fatty and spicy foods: these can make nausea worse and cause gastric discomfort
  • Ginger and mint: ginger and mint can help relieve nausea, you can try ginger or mint tea.
  • Daily walks: walking at a moderate pace for at least 30-40 minutes a day can improve mood and reduce fatigue.
  • Yoga: yoga combines physical exercise with breathing and meditation techniques, which can help reduce stress and improve flexibility and strength.
  • Exercise: activities such as swimming or cycling are excellent options for staying active, but you should also include strength exercises.
  • Gentle stretching: gentle stretching can help maintain flexibility and reduce muscle tension.
  • Relaxation techniques: practicing meditation, deep breathing and mindfulness can help calm the mind and reduce anxiety.
  • Professional counseling: consider talking to a therapist specializing in oncology, they can help manage stress, anxiety and others.

Letrozole is a drug used primarily in the treatment of breast cancer in postmenopausal women. As an aromatase inhibitor, it reduces the levels of estrogen in the body, helping to prevent the growth of hormone-dependent cancer cells. It is effective in the treatment of hormone-dependent breast cancer, both in the adjuvant and metastatic contexts.

It is essential to strictly follow the doctor’s instructions, especially regarding the duration of treatment, and not to interrupt it without medical consultation.

 

Dr. Rosa María Morera

Radiation Oncology

  • Specialist in Radiation Oncology.
  • Degree in Medicine and Surgery.  Faculty of Medicine, Complutense University of Madrid (2-8-1990).
  • Head of the Radiation Oncology Department, Hospital Universitario La Paz, Madrid.
  • Expert with university micro-credential mention in Physics, Technology and Protontherapy. King Juan Carlos University.
  • Higher University Course in Design and Management of Proton Therapy Centres. King Juan Carlos University.
  • XIX Programme of Senior Management in Health Institutions. IESE Business School. University of Navarra.
  • Master in Administration and Management of Health Services XXIV Edition (2013-2014). Pompeu Fabra University.
  • Doctoral Thesis Reading: ‘Radical thoracic irradiation and pulmonary functional study in patients with locally advanced non-small cell lung cancer. Systematic review and prospective case series’ . Qualification of outstanding ‘cum laude’.
  • Doctorate courses: Complutense University of Madrid (1995-1997).
  • She is a researcher in numerous clinical trials, publishing several national and international scientific articles.

Dr. Jose María Oliver

Breast radiology

  • Breast radiologist and specialist in cryoblation of breast lesions in the IVOQA Breast Unit.
  • Degree in Medicine and Surgery from the University of Navarra (1983-1989). Specialisation via MIR in Radiology. Number 289.
  • Specialist in radiology in several renowned hospitals, international reference and pioneer in the application of cryoablation to breast pathology in Spain.
  • Head of the Breast Radiology Section at the Hospital Universitario La Paz.
  • Member of the Spanish Society of Medical Radiology (SERAM) and the Spanish Society of Diagnostic Imaging (SEDIM).

Dr. Jesús Cañete Gómez

General and Digestive Surgery. Oncological Surgery

  • Graduate in Medicine and Surgery from the University of Seville (2000- 2006).
  • Specialist in colon and rectal cancer surgery using a minimally invasive approach.
  • Training in transanal rectal cancer treatment (TAMIS and TaTME).
    Training in minimally invasive surgery at Jackson Memorial Hospital (Miami).
  • Specialist in General Surgery at Viamed Fatima Hospital, Seville (currently).
  • Doctor of Medicine from the University of Seville (‘cum laude’).
  • Associate Professor at the University of Seville Founder of the surgical team Laparoscopic Surgery Seville – MISS (Minimally Invasive Surgical Solutions) – minimally invasive surgical techniques in scheduled and emergency surgery.
  • He has written numerous publications in journals and books and is a member of the Spanish Society of Obesity Surgery (SECO), as well as the Spanish Association of Surgeons (AEC) and the Andalusian Association of Surgeons (ASAC).

Dr. Juan José Segura Sampedro

General and digestive surgery. Oncological Surgery

  • Degree in Medicine and Surgery from the University of Seville. 2003-2009.
  • Specialist in peritoneal carinomatosis.
  • Doctor of Medicine from the University of Seville (‘cum laude’).
  • Oncological Surgeon in the Section of Peritoneal, Retroperitoneal and Soft Parts Oncological Surgery, Department of General and Digestive System Surgery, Hospital Universitario La Paz, Madrid.
  • Associate Professor of Surgery, Faculty of Medicine, University of the Balearic Islands, Palma de Mallorca.
  • 3IP in the Research Group in Advanced Oncological Surgery, m-Health and Innovation in Surgical Technology, Institute for Health Research of the Balearic Islands (IdISBa), Palma de Mallorca.
  • He has written numerous publications in journals and books and is a member of the Spanish Society of Surgical Oncology (SEOQ), the Spanish Society of Coloproctology (AECP), the Spanish Association of Surgeons (AEC), the European Society of Oncological Surgery (ESSO) and the Spanish Group of Peritoneal Oncological Surgery (GECOP).

Pablo Soto

Specialist in sports training for oncology patients

  • Higher Degree in Dietetics (2020-2022)
  • Treatment and rehabilitation of cancer patients

Dr. Gonzalez Larriba

Medical oncology

  • Professor of Medical Oncology at the Complutense University of Madrid
  • Head of the Medical Oncology Section of the Hospital Clínico San Carlos in possession of the European Certificate in Oncology
  • Recognition of 6 six-year research periods + 1 six-year period of knowledge transfer
  • Master in Oncology Services Management by the University of Alcala de Henares
  • Visiting Professor of Oncology at the University of Palermo (Italy)
  • Multiple stays in international centres (Memorial Sloan Kettering Cancer Center, Gustave Roussy Institute, University of Lyon, Princess Margaret Hospital in Toronto, University of Pittsburgh)
  • Maximum recognition of the Professional Career by the Regional Ministry of Health of the Community of Madrid
  • Director of the Master’s Degree in Genitourinary Tumours at the Complutense University of Madrid
  • Founder and member of the Board of Directors of the Spanish Lung Cancer Group, Spanish Genitourinary Tumour Group and Spanish Melanoma Group
  • Member of the Board of Directors of the Spanish Society of Medical Oncology
  • Miembro de la European Society of Medical Oncology, American Society of Clinical Oncology, International Association for the Study od Lung Cancer, etc.
  • Author of more than 300 scientific articles, 400 conference papers and 60 scientific books, as well as speaker in more than 400 conference papers

Francisco Flores

Physiotherapy

  • Graduate in physiotherapy. UEM.
  • Master’s degree in respiratory physiotherapy. UNIVERSITAT
  • ROVIRA i VIRGILI.
  • MASTER specialist in conservative and invasive physiotherapy of myofascial pain syndrome and fibromyalgia. UAH.
  • SPIROMETRIST by the ERS-SEPAR for the performance and interpretation of SPIROMETRY.
  • MASTER Specialist in intratissue percutaneous electrolysis treatments EPI.
  • Specialist in the use and application of the INDIBA ACTIV system.
  • MASTER Specialist in Biomechanical Analysis, Intervention and Treatment “Check yourMOtion”.
  • NATIONAL CLASSIFIER for athletes with cerebral palsy.
  • NATIONAL CLASSIFIER of athletics for people with physical disabilities.
  • RESEARCH PROJECT: “Respiratory physiotherapy as a treatment for ARVC in high performance athletes”.

Dr. Javier Heras Aznar

BREAST UNIT

  • Graduate in Medicine and Surgery from Universidad Autonoma de Madrid 1992.
  • Specialist via MIR in Family Medicine at Hospital Universitario Ramón y Cajal 1994-1996.
  • Specialist via MIR in OBSTETRICS AND GYNECOLOGY at Hospital Universitario Santa Cristina in Madrid 1997-2001.
  • Specialized in the last 27 years in Gynecological Oncology and Breast Pathology, both malignant and benign, with experience in Oncoplastic Surgery.
  • Specialization Course in Oncoplastic Breast Surgery 2015.
  • Coordinator of the Breast Unit and the Breast Tumors and Gynecology Oncology Committee in Hospital Universitario Infanta Sofía.
  • Main Author of the Breast Unit Accreditation Project (Hospital Universitario Infanta Sofía) 2019-2020.

Dr. Beatriz García-Conde

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Puerta de Hierro University Hospital in Majadahonda. Currently working at the 12 de Octubre University Hospital.
  • Specialist in capsule endoscopy and in diagnostic and therapeutic endoscopy: chromoendoscopy, colon cancer screening, digestive dilatations, PEG placement, endoluminal vacuum therapy (fistulas/leaks), polypectomy/mucosectomy.
  • She also a general digestive consultant with a Master’s Degree in Neurogastroenterology.

Dr. Micaela Riat Castro Zocchi

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Princesa Hospital (Madrid).
  • Clinical consultation. Diagnostic and therapeutic endoscopy: Chromoendoscopy, Colon Cancer Screening, Placement of digestive prosthesis (oesophagus, colon), Digestive dilatations, PEG Placement, Endoluminal Vacuum Therapy (fistulas/leaks), Polypectomy/mucosectomy. Experience in Bariatric Endoscopy: Intragastric balloon.

Dr. Diana Fresneda Cuesta

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Jiménez Díaz Foundation. (Madrid)
  • Clinical consultation. Specialist in Endoscopic Capsule and in Diagnostic and Therapeutic Endoscopy: Chromoendoscopy, Colon Cancer Screening, Ligation of Oesophagus Varices, Placement of digestive prosthesis (oesophagus, colon), Digestive dilatations, PEG Placement, Endoluminal Vacuum Therapy (fistulas/leaks), Polypectomy/mucosectomy. Experience in bariatric endoscopy: intragastric balloon, POSE method and Endo-sleeve with POSE system, etc.

Dr. Teresa Valdés Lacasa

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery
  • MIR specialisation in Digestive System Medicine, 12 de Octubre University Hospital (Madrid). Advanced Endoscopy Fellowship (ERCP and digestive prostheses) at Ninewells Hospital (United Kingdom). 2020-2021.
  • Clinical consultation and abdominal ultrasound.
  • Specialist in pancreatico-biliary conditions and therapeutic endoscopy: ERCP, placement of digestive prostheses (oesophagus, duodenum, colon, biliary), digestive dilatations, placement of PEGs, endoluminal vacuum therapy (fistulas/leaks), polypectomy/mucosectomy.

Dr. Andrés J. del Pozo García, MD. PhD.

DUAL SPECIALISATION IN DIGESTIVE SYSTEM MEDICINE / FAMILY AND COMMUNITY MEDICINE

  • Graduate in Medicine and Surgery.
  • Dual specialised training (MIR) at the Princesa University Hospital (Madrid).
  • Specialist in Digestive System Medicine and Specialised in Family and Community Medicine
  • PhD in Medicine from the Autonomous University of Madrid. Cum Laude. 2020.
  • Member of S.E.P.D, S.E.E.D., A.E.G, E.S.G.E, AESPANC, Board Member of GETTEMO; Consultant of Apollo Endosurgery in 2021.

Dr. José María Abadal Villayandre

SPECIALIST IN VASCULAR INTERVENTIONAL RADIOLOGY

  • Graduate in Medicine and Surgery from Navarra University.
  • MIR specialisation in Radiology, Radiodiagnosis at Gregorio Marañón University Hospital.
  • PhD in Radiodiagnosis from the Complutense University of Madrid. Cum Laude Doctoral Thesis.
  • Specialist in Vascular Interventional Radiology, accreditation from the Spanish Society of Interventional Radiology.
  • European Board Interventional Radiology (EBIR) Health Sciences) at Alfonso X el Sabio University. 2010-2014.
  • Medical Director of the “Centro de Radiología y Diagnóstico por Imagen”.
  • Scientific and research activity with numerous publications and research studies.
  • Director and professor of Interventional Vascular Radiology at the I-XI Endo-school. Teaching activity.
  • Member of SERAM (Spanish Society of Medical Radiology), CIRSE (Cardiovascular Interventional Radiology Society Europe), and Secretary of SERVEI (Spanish Society of Interventional Vascular Radiology).

Belén Pérez Peiro. Psychologist

SPECIALIST IN PSYCHO-ONCOLOGY

  • Graduate in Psychology
  • Clinical psychologist, Gregorio Marañón University General Hospital, Psycho-oncology, Gynaecological Psychology, Neuropsychology, Detoxification and Out-patient Hospital, inflammatory bowel disease and teenagers.
  • Clinical activity at the Niño Jesús Children’s University Hospital, Psychiatric and Eating Disorder Units.
  • Expert qualification in Psychosomatic Medicine and Health Psychology.
  • Expert qualification in Psychopathology and Psychiatry from the Spanish Society of Psychosomatic Medicine and Medical Psychology.
  • Specialist qualification in Psychotherapy and projective techniques, both of which are recognised by the Madrid Official Association of Psychologists.

Dr. Ana María Moreno

SPECIALIST IN INTERNAL MEDICINE AND NUTRITIONAL PREHABILITATION

  • Graduate in Medicine and Surgery. 1986– 1992.
  • Extraordinary Graduation Award. 1992.
  • MIR specialisation in Internal Medicine. Number 283.
  • Master’s Degree in Palliative Care from Valladolid University. 2011.
  • University Master’s Degree in Advanced Chronic Nursing and palliative care from Antonio de Nebrija University. 2017.
  • PhD Courses 1993.
  • Extensive professional career in many renowned hospitals.
  • Head of Internal Medicine Services at Viamed Santa Elena (Madrid). September 2021 – Present.
  • Teaching and research work.
  • Numerous publications and papers. Participation in courses and seminars.